title: Prevention of nephropathy in patients with type 2 diabetes mellitus.
abstract: The rising incidence of type 2 diabetes mellitus and of its complications will make it the most important health care challenge in the first quarter of the 21st Century. Diabetic nephropathy left unchecked will overwhelm the renal resources. Simple methods (proper diet and exercise, prevention of obesity) are successful in preventing type 2 diabetes in the great majority of the persons at risk. In patients with established type 2 diabetes, nephropathy can be prevented or greatly delayed by strict metabolic control, strict control of blood pressure using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as the first line of drugs, tight control of serum lipids using statins as indicated, low protein diet, avoidance of smoking and other nephrotoxic influences, prevention of abnormalities in calcium/phosphorus metabolism, and prevention of renal anemia by the early use of erythropoietin. Current research offers the promise of definitive prevention of both type 2 diabetes and diabetic nephropathy.
authors.affiliation: Section of Nephrology, Renal Section (111C), New Mexico Veterans Affairs Health Care System, Albuquerque, New Mexico 87108, USA. Antonios.tzamaloukas@med.va.gov
authors.forename: Antonios H
authors.initials: AH
authors.lastname: Tzamaloukas
authors.forename: Glen H
authors.initials: GH
authors.lastname: Murata
mesh_terms: D000419:Albuminuria / Q000209:etiology; D000740:Anemia / Q000188:drug therapy; D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics; D003928:Diabetic Nephropathies / Q000453:epidemiology / Q000517:prevention & control*; D018450:Disease Progression; D004921:Erythropoietin / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology; D008928:Mitochondria / Q000502:physiology
chemical_list: D004921:Erythropoietin